van Sorge AJ[au] - Search Results

Year	Number of Results
2010	1
2011	1
2012	1
2013	2
2014	2
2015	1
2017	1
2021	1
2022	1
2023	0

1

Editorial: Cerebral visual impairment, visual development, diagnosis, and rehabilitation.

Bauer CM, van Sorge AJ, Bowman R, Boonstra FN. Bauer CM, et al. Among authors: van sorge aj. Front Hum Neurosci. 2022 Nov 15;16:1057401. doi: 10.3389/fnhum.2022.1057401. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36457755 Free PMC article. No abstract available.

2

Nationwide inventory on retinopathy of prematurity screening in the Netherlands.

Trzcionkowska K, Termote JU, Böhringer S, van Sorge AJ, Schalij-Delfos N. Trzcionkowska K, et al. Among authors: van sorge aj. Br J Ophthalmol. 2021 Dec 10:bjophthalmol-2021-319929. doi: 10.1136/bjophthalmol-2021-319929. Online ahead of print. Br J Ophthalmol. 2021. PMID: 34893474 Free article.

3

A translucent vascularised iris granuloma in a patient with secondary syphilis.

de Jong Y, Haverkort ME, van Sorge AJ, Jansen C, Luyten GP, Joosse M. de Jong Y, et al. Among authors: van sorge aj. Lancet Infect Dis. 2017 Mar;17(3):255-256. doi: 10.1016/S1473-3099(17)30071-3. Epub 2017 Feb 23. Lancet Infect Dis. 2017. PMID: 28244379 No abstract available.

4

Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands.

van Sorge AJ, Termote JU, Simonsz HJ, Kerkhoff FT, van Rijn LJ, Lemmens WA, Schalij-Delfos NE. van Sorge AJ, et al. Br J Ophthalmol. 2014 Aug;98(8):1056-60. doi: 10.1136/bjophthalmol-2013-304493. Epub 2014 Mar 28. Br J Ophthalmol. 2014. PMID: 24682181

5

Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands.

van Sorge AJ, Termote JU, Kerkhoff FT, van Rijn LJ, Simonsz HJ, Peer PG, Schalij-Delfos NE. van Sorge AJ, et al. J Pediatr. 2014 Mar;164(3):494-498.e1. doi: 10.1016/j.jpeds.2013.11.015. Epub 2013 Dec 19. J Pediatr. 2014. PMID: 24360994

6

Exposure keratopathy following silicone frontalis suspension in adult neuro- and myogenic ptosis.

van Sorge AJ, Devogelaere T, Sotodeh M, Wubbels R, Paridaens D. van Sorge AJ, et al. Acta Ophthalmol. 2012 Mar;90(2):188-92. doi: 10.1111/j.1755-3768.2010.01876.x. Epub 2010 Mar 8. Acta Ophthalmol. 2012. PMID: 20222904 Free article.

7

Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria.

van Sorge AJ, Schalij-Delfos NE, Kerkhoff FT, van Rijn LJ, van Hillegersberg JL, van Liempt IL, Peer PG, Simonsz HJ, Termote JU. van Sorge AJ, et al. Br J Ophthalmol. 2013 Sep;97(9):1143-7. doi: 10.1136/bjophthalmol-2013-303123. Epub 2013 Jul 3. Br J Ophthalmol. 2013. PMID: 23823079

8

Cost and effects of risk factor guided screening strategies for retinopathy of prematurity for different treatment strategies.

van den Akker-van Marle ME, van Sorge AJ, Schalij-Delfos NE. van den Akker-van Marle ME, et al. Among authors: van sorge aj. Acta Ophthalmol. 2015 Dec;93(8):706-12. doi: 10.1111/aos.12798. Epub 2015 Jul 6. Acta Ophthalmol. 2015. PMID: 26149829 Free article.

9

The incidence of visual impairment due to retinopathy of prematurity (ROP) and concomitant disabilities in the Netherlands: a 30 year overview.

van Sorge AJ, Termote JU, de Vries MJ, Boonstra FN, Stellingwerf C, Schalij-Delfos NE. van Sorge AJ, et al. Br J Ophthalmol. 2011 Jul;95(7):937-41. doi: 10.1136/bjo.2010.192542. Epub 2011 Feb 10. Br J Ophthalmol. 2011. PMID: 21310801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results